UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004327
Receipt No. R000005012
Scientific Title Phase II Study of induction Carboplatin+Paclitaxel+Bevacizumab combination therapy for stage III Non-Small-Cell Lung Cancer (NSCLC)
Date of disclosure of the study information 2010/10/05
Last modified on 2019/04/20 14:04:59

No. Disposal Last modified on Item of update
1 Insert 2010/10/05 12:45:51
2 Update 2011/06/14 14:55:29 Anticipated trial start date
3 Update 2011/06/15 10:50:02 Last follow-up date
4 Update 2011/10/05 09:55:31 Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2011/11/10 12:00:15 Address
Address
Address1
6 Update 2013/02/05 14:21:48 Recruitment status
7 Update 2014/06/17 10:18:42 Recruitment status
Publication of results
URL related to results and publications
8 Update 2014/06/17 10:19:42 Recruitment status
9 Update 2014/12/04 10:20:25 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
TEL
Email
Name of person sending information
Name of person sending information
Email
10 Update 2015/02/04 09:18:52 Email
Email1
11 Update 2019/04/20 14:04:59 Recruitment status
Date of IRB
Date analysis concluded


Contact us.